- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $265.07M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $254.16M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $122.61M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $130.35M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $328.67M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $336.42M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $330.6M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $326.05M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $682.76M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $676.49M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 119.14M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $14.44M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $19.93M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $316.19M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $301.79M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.02 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.02 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $118.59M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$2.68M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$5.13M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $113.46M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $86.54M |
| Revenue | Q1 2025 · Mar 31, 2024 | $200M |